All Stories

  1. FOXO3 Longevity Genotype Mitigates Risk Posed by Hypertension on Incident Coronary Artery Disease in Middle-aged Men: Kuakini Honolulu Heart Program
  2. Comments on Fendereski et al., Comparing Penile Problems in Circumcised vs. Uncircumcised Boys: Insights From a Large Commercial Claims Database With a Focus on Provider Type Performing Circumcision
  3. Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’
  4. Circumcision policy by Australian physicians' organisation is a threat to community health
  5. Novel protective effect of the FOXO3 longevity genotype on mechanisms of cellular aging in Okinawans
  6. Neonatal Male Circumcision: Clearly Beneficial for Public Health or an Ethical Dilemma? A Systematic Review
  7. Comment on “Comparison the Diameter of the Urethral Meatus Before and After Circumcision and Evaluation of Urethral Stenosis”
  8. Flaws in arguments by opponents of childhood male circumcision
  9. FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk
  10. Incidence of Alzheimer’s Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype
  11. Genes That Extend Lifespan May Do So by Mitigating the Increased Risk of Death Posed by Having Hypertension
  12. Vascular endothelial growth factor receptor 1 gene (FLT1) longevity variant increases lifespan by reducing mortality risk posed by hypertension
  13. Letter to Editor regarding: Referrals from primary care with foreskin symptoms: Is there really room for improvement?
  14. Proteomic basis of mortality resilience mediated by FOXO3 longevity genotype
  15. Infant Circumcision for Sexually Transmitted Infection Risk Reduction Globally
  16. Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage
  17. FOXO3, a Resilience Gene: Impact on Lifespan, Healthspan, and Deathspan
  18. Re: The medical evidence on non-therapeutic circumcision of infants and boys—setting the record straight
  19. Critical evaluation of contrasting evidence on whether male circumcision has adverse psychological effects: A systematic review
  20. Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity
  21. Circumcision and Risk of HIV among Males from Ontario, Canada. Letter.
  22. Evidence-based circumcision policy for Australia
  23. Re: Sensory innervation of the human male prepuce—Meissner’s corpuscles predominate
  24. Causes and consequences of the decline in circumcision in Australia
  25. Association with Longevity of Phosphatidylinositol 3-Kinase Regulatory Subunit 1 Gene Variants Stems from Protection against Mortality Risk in Men with Cardiovascular Disease
  26. Association of growth hormone receptor gene variant with longevity in men is due to amelioration of increased mortality risk from hypertension
  27. Lifespan extension conferred by mitogen-activated protein kinase kinase kinase 5 (MAP3K5) longevity-associated gene variation is confined to at-risk men with a cardiometabolic disease
  28. FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease
  29. Voluntary Medical Male Circumcision Proves Robust for Mitigating Heterosexual Human Immunodeficiency Virus Infection
  30. The Contrasting Evidence Concerning the Effect of Male Circumcision on Sexual Function, Sensation, and Pleasure: A Systematic Review
  31. Prevalence of Phimosis in Males of All Ages: Systematic Review
  32. The advent of human papillomavirus detection for cervical screening
  33. In silico analysis of human renin gene–gene interactions and neighborhood topologically associated domains suggests breakdown of insulators contribute to ageing-associated diseases
  34. Critical evaluation of arguments opposing male circumcision: A systematic review
  35. Genetic and epigenetic regulation of human aging and longevity
  36. Sex and Male Circumcision: Women’s Preferences Across Different Cultures and Countries: A Systematic Review
  37. The role of oxygen in regulating microRNAs in control of the placental renin–angiotensin system
  38. Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?
  39. Letter by Morris Regarding Article, “Genetics of Human Longevity Within an Eco-Evolutionary Nature-Nurture Framework”
  40. Meatal stenosis: getting the diagnosis right
  41. Letter to the Editor
  42. Reply by the Authors
  43. Regulation of the human placental (pro)renin receptor-prorenin-angiotensin system by microRNAs
  44. Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele
  45. Re: Cultural background, non-therapeutic circumcision and the risk of meatal stenosis and other urethral stricture disease: Two nationwide register-based cohort studies in Denmark 1977–2013
  46. Transcriptomics in Twins Separates Genetic From Environmental Effects on Gene Expression and Blood Pressure
  47. FOXO3 and Exceptional Longevity: Insights From Hydra to Humans
  48. Analysis of Polymorphisms in 59 Potential Candidate Genes for Association With Human Longevity
  49. FOXO3 cell resilience gene neighborhood
  50. Does Circumcision Increase Meatal Stenosis Risk?—A Systematic Review and Meta-analysis
  51. Effect of male circumcision on risk of sexually transmitted infections and cervical cancer in women
  52. Blood Pressure Genome-Wide Association Studies, Missing Heritability, and Omnigenics
  53. Longevity "gene factory"
  54. Gene Team in Blood Pressure Genetics
  55. CDC's Male Circumcision Recommendations Represent a Key Public Health Measure
  56. Infant circumcision: Evidence, policy, and practice
  57. Penile inflammatory skin disorders and the preventive role of circumcision
  58. Early infant male circumcision: Systematic review, risk-benefit analysis, and progress in policy
  59. Expertise and Ideology in Statistical Evaluation of Circumcision for Protection against HIV Infection
  60. Re: Examining Penile Sensitivity in Neonatally Circumcised and Intact Men Using Quantitative Sensory Testing
  61. Longevity-AssociatedFOXO3Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations
  62. Association of Polymorphisms in Connective Tissue Growth Factor and Epidermal Growth Factor Receptor Genes With Human Longevity
  63. The FoxO3 gene and cause‐specific mortality
  64. Circumcision is a primary preventive against HIV infection: Critique of a contrary meta-regression analysis by Van Howe
  65. Erratum to: Estimation of country-specific and global prevalence of male circumcision
  66. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer
  67. Estimation of country-specific and global prevalence of male circumcision
  68. Countries with high circumcision prevalence have lower prostate cancer mortality
  69. Critical evaluation of unscientific arguments disparaging affirmative infant male circumcision policy
  70. Reply to Letter by Dr. Christoph Kupferschmid: Commentary on "Countries with high circumcision prevalence have lower prostate cancer mortality"
  71. Effect of oxygen on the expression of renin–angiotensin system components in a human trophoblast cell line
  72. Implications of circumcision complications for hospital policy
  73. Male circumcision to prevent syphilis in 1855 and HIV in 1986 is supported by the accumulated scientific evidence to 2015: Response to Darby
  74. Association Analysis ofFOXO3Longevity Variants With Blood Pressure and Essential Hypertension
  75. Commentary: Do the Benefits of Male Circumcision Outweigh the Risks? A Critique of the Proposed CDC Guidelines
  76. Brain-stem microRNAs implicated in hypertension
  77. In developed countries male circumcision prevalence is inversely related to HIV prevalence
  78. Blood Pressure Genetics Just Don’t Add Up
  79. ‘Circumcision pain’ unlikely to cause autism
  80. Effect of male circumcision on sexual function
  81. The literature supports policies promoting neonatal male circumcision in north america.
  82. Debating male circumcision for HIV prevention: A one-sided argument does not represent a legitimate ‘controversy’ analysis – Reply to de Camargo et al.
  83. Male circumcision for protection against HIV infection in sub-Saharan Africa: The evidence in favour justifies the implementation now in progress
  84. Renin, Genes, MicroRNAs, and Renal Mechanisms Involved in Hypertension
  85. <b><i>FOXO3:</i></b> A Major Gene for Human Longevity - A Mini-Review
  86. Signatures of miR-181a on the Renal Transcriptome and Blood Pressure
  87. Scientific evidence dispels false claims about circumcision
  88. In reply—Bias and Male Circumcision
  89. Genetic Variation in the Raptor Gene Is Associated With Overweight But Not Hypertension in American Men of Japanese Ancestry
  90. Shorter Men Live Longer: Association of Height with Longevity and FOXO3 Genotype in American Men of Japanese Ancestry
  91. Circumcision Rates in the United States: Rising or Falling? What Effect Might the New Affirmative Pediatric Policy Statement Have?
  92. Analysis of genes in a key pathway to see if any are involved in the genetic basis of longevity
  93. Circumcision Is a Religious/Cultural Procedure, Not a Medical Procedure—Reply
  94. Does Male Circumcision Protect against Sexually Transmitted Infections? Arguments and Meta-Analyses to the Contrary Fail to Withstand Scrutiny
  95. Circumcision does not alter sexual function, sensitivity or pleasure for men
  96. Legal Threat to Infant Male Circumcision
  97. A Novel Interaction Between Sympathetic Overactivity and Aberrant Regulation of Renin by miR-181a in BPH/2J Genetically Hypertensive Mice
  98. Recommendation by a law body to ban infant male circumcision has serious worldwide implications for pediatric practice and human rights
  99. Veracity and rhetoric in paediatric medicine: a critique of Svoboda and Van Howe's response to the AAP policy on infant male circumcision
  100. Association Analyses of Insulin Signaling Pathway Gene Polymorphisms With Healthy Aging and Longevity in Americans of Japanese Ancestry
  101. Circumcision and Lifetime Risk of Urinary Tract Infection: A Systematic Review and Meta-Analysis
  102. ZRANB2 localizes to supraspliceosomes and influences the alternative splicing of multiple genes in the transcriptome
  103. Male circumcision decreases penile sensitivity as measured in a large cohort
  104. Seven sirtuins for seven deadly diseases ofaging
  105. Legal arguments opposing infant male circumcision are flawed
  106. Should Male Circumcision be Advocated for Genital Cancer Prevention?
  107. BOYLE AND HILL'S CIRCUMCISION ‘PHALLUSIES’
  108. The 2010 Royal Australasian College of Physicians' policy statement ‘Circumcision of infant males’ is not evidence based
  109. Circumcision reduces prostate cancer risk
  110. Neurogenic Hypertension: Revelations from Genome-Wide Gene Expression Profiling
  111. Review: A critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries
  112. Biological basis for the protective effect conferred by male circumcision against HIV infection
  113. A 'snip' in time: what is the best age to circumcise?
  114. Letter by Marques and Morris Regarding Article, “Signature MicroRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection”
  115. Benefits of Male Circumcision
  116. Current Medical Evidence Supports Male Circumcision
  117. Infant male circumcision: An evidence-based policy statement
  118. Fetal Sex Affects Expression of Renin-Angiotensin System Components in Term Human Decidua
  119. Resveratrol, by Modulating RNA Processing Factor Levels, Can Influence the Alternative Splicing of Pre-mRNAs
  120. Gene Expression Profiling Reveals Renin mRNA Overexpression in Human Hypertensive Kidneys and a Role for MicroRNAs
  121. A “SNP in Time” for SCNN1G to Join the “Highly Likely” List of Genes for Essential Hypertension
  122. Does sexual function survey in Denmark offer any support for male circumcision having an adverse effect?
  123. Male Circumcision: An Appraisal of Current Instrumentation
  124. Exposé of fallacious claims that male circumcision will increase HIV infections in Africa
  125. ‘How to contain generalized HIV epidemics’ article misconstrues the evidence
  126. Genes Influencing Circadian Differences in Blood Pressure in Hypertensive Mice
  127. Circumcision Denialism Unfounded and Unscientific
  128. Renin, Genes, and Beyond
  129. Molecular characterization of renin-angiotensin system components in human intrauterine tissues and fetal membranes from vaginal delivery and cesarean section
  130. Renin
  131. Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa
  132. The Strong Protective Effect of Circumcision against Cancer of the Penis
  133. Circumcision survey misleading
  134. Commentary on Resveratrol and Hormesis: Resveratrol—a hormetic marvel in waiting?
  135. The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV
  136. Meta-Analysis of Genome-Wide Gene Expression Differences in Onset and Maintenance Phases of Genetic Hypertension
  137. Keratinization of the adult male foreskin and implications for male circumcision
  138. Sympathetic Meta-Analysis of Adrenoceptor Gene Variants in Hypertension
  139. The molecular basis of longevity, and clinical implications
  140. Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits
  141. Hormesis as a Pro-Healthy Aging Intervention in Human Beings?
  142. MEDICAID COVERAGE OF NEWBORN CIRCUMCISION: A HEALTH PARITY RIGHT OF THE POOR
  143. Might a Leptin Gene Variant Affect Blood Pressure in Obese Brazilians?
  144. The zinc fingers of the SR-like protein ZRANB2 are single-stranded RNA-binding domains that recognize 5′ splice site-like sequences
  145. Xylosyltransferase Gene Variants and Their Role in Essential Hypertension
  146. RBM4: A multifunctional RNA-binding protein
  147. Errors in meta-analysis by Van Howe
  148. GRK4 Genetics and Response to  -Blocker
  149. FLUORESCENCE ACTIVATED CELL SORTING OF TRANSIENTLY TRANSFECTED As4.1 CELLS SHOWS RENIN ENHANCER DIRECTS ON/OFF SWITCHING OF RENIN PROMOTER IN VITRO
  150. Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice?
  151. ZRANB2: Structural and functional insights into a novel splicing protein
  152. Re: ‘RS Van Howe, FM Hodges. The carcinogenicity of smegma: debunking a myth.’ An example of myth and mythchief making?
  153. Renin Enhancer Is Crucial for Full Response in Renin Expression to an In Vivo Stimulus
  154. Why circumcision is a biomedical imperative for the 21stcentury
  155. The Effect of Resveratrol on a Cell Model of Human Aging
  156. Reduced Cardiovascular Reactivity to Stress but Not Feeding in Renin Enhancer Knockout Mice
  157. FINE‐TOUCH PRESSURE THRESHOLDS IN THE ADULT PENIS
  158. CASE NUMBER AND THE FINANCIAL IMPACT OF CIRCUMCISION IN REDUCING PROSTATE CANCER
  159. The Human Pseudoautosomal Region (PAR): Origin, Function and Future
  160. Identification of a Novel Polymorphism in the 3′UTR of the l -Arginine Transporter Gene SLC7A1
  161. Climate not cultivars in the NO-ing of red wines
  162. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  163. Circumcision in Australia: prevalence and effects on sexual health
  164. Re: Cost Analysis of Neonatal Circumcision in a Large Health Maintenance Organization
  165. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo
  166. XE7: A novel splicing factor that interacts with ASF/SF2 and ZNF265
  167. Renin Enhancer Is Critical for Control of Renin Gene Expression and Cardiovascular Function
  168. Lark Is the Splicing Factor RBM4 and Exhibits Unique Subnuclear Localization Properties
  169. RACP's policy statement on infant male circumcision is ill-conceived
  170. Dietary approaches that delay age-related diseases
  171. Dissecting Hypertension by Obesity Identifies a Locus at 1p36
  172. No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36
  173. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer
  174. Genome-Wide Scan for Hypertension in Sydney Sibships: The GENIHUSS Study
  175. Angiotensin receptor gene variant goes with the flow
  176. BRCTx Is a Novel, Highly Conserved RAD18-Interacting Protein
  177. Cervical human papillomavirus screening by PCR: advantages of targeting the E6/E7 region
  178. Critique of ?sibpair studies implicate chromosome 18 in essential hypertension? by S. Rutherford, M.P. Johnson, and L.R. Griffiths. 2004. Am J Med Genet 126A:241-247
  179. The scorching breath of angiotensin
  180. cAMP controls human renin mRNA stability via specific RNA‐binding proteins
  181. No association of Angiotensin-Converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension*1
  182. Circumcision rate too low?
  183. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension
  184. Chromatic and spatial properties of parvocellular cells in the lateral geniculate nucleus of the marmoset (Callithrix jacchus)
  185. WNK4 Intron 10 Polymorphism Is Not Associated With Hypertension
  186. HADHB, HuR, and CP1 Bind to the Distal 3′-Untranslated Region of Human Renin mRNA and Differentially Modulate Renin Expression
  187. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension
  188. Tumor necrosis factor receptor 2 mRNA in rat models of hypertension
  189. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension
  190. Association of Obesity, but not Diabetes or Hypertension, with Glucocorticoid Receptor N363S Variant
  191. The Structure of the Zinc Finger Domain from Human Splicing Factor ZNF265 Fold
  192. Renin: from ‘pro’ to promoter
  193. Association of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant
  194. Essential Hypertension: Genes and Dreams
  195. Overweight, But Not Hypertension, Is Associated with SAH Polymorphisms in Caucasians with Essential Hypertension
  196. Lipopolysaccharide Reverses Adrenocorticotrophic Hormone-Induced Hypertension in the Rat
  197. A Distinct Subclass of Mammalian Striated Myosins: Structure and Molecular Evolution of "Superfast" or Masticatory Myosin Heavy Chain
  198. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes
  199. Association analysis of polymorphisms at the interleukin‐1 locus in essential hypertension
  200. Critique of “Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension” by Rutherford et al., Human Genetics, published online September 2001
  201. RENIN GENE EXPRESSION: THE SWITCH AND THE FINGERS
  202. Association of β2-adrenoceptor Gln27Glu variant with body weight but not hypertension
  203. ZNF265—a novel spliceosomal protein able to induce alternative splicing
  204. G-protein β3 subunit gene splice variant in obesity and overweight
  205. TNFRSF1Bin Genetic Predisposition to Clinical Neuropathy and Effect on HDL Cholesterol and Glycosylated Hemoglobin in Type 2 Diabetes
  206. Decreased Renal Expression of Nitric Oxide Synthase Isoforms in Adrenocorticotropin-Induced and Corticosterone-Induced Hypertension
  207. Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease
  208. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension
  209. Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor
  210. Chromosome localization and characterization of the mouse and human zinc finger protein 265 gene
  211. Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
  212. High penetrance, overweight, and glucocorticoid receptor variant: case-control study
  213. Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity
  214. The Gly460Trp variant of α-adducin is not associated with hypertension in white anglo-Australians
  215. Different Frequencies of Inducible Nitric Oxide Synthase Genotypes in Older Hypertensives
  216. G-Protein β3 Subunit Gene ( GNB3 ) Variant in Causation of Essential Hypertension
  217. SCANNING THE GENOME FOR ESSENTIAL HYPERTENSION LOCI
  218. A LINKAGE AND CROSS‐SECTIONAL STUDY OF HYPERTENSION AND OBESITY USING A POLY(A) Alu‐REPEAT POLYMORPHISM AT THE GLUCAGON RECEPTOR GENE LOCUS (17q25)
  219. Insulin receptor exon 11+/− isoform mRNA in spontaneously hypertensive and adrenocorticotropin-hypertensive rats
  220. Association of a low density lipoprotein receptor microsatellite variant with obesity
  221. Association Analyses of SA Gene Variant in Essential Hypertensives
  222. Insulin Receptor Gene in Hypertension
  223. Transactivation of the Human Renin Promoter by the Cyclic AMP/Protein Kinase A Pathway Is Mediated by Both cAMP-responsive Element Binding Protein-1 (CREB)-dependent and CREB-independent Mechanisms in Calu-6 Cells
  224. Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension
  225. HYPOTHESIS: GLUCAGON RECEPTOR GLYCINE TO SERINE MISSENSE MUTATION CONTRIBUTES TO ONE IN 20 CASES OF ESSENTIAL HYPERTENSION*
  226. Effect of angiotensin-converting enzyme genotype on renin-angiotensin components in hypertensives
  227. Transcriptional and posttranscriptional mechanisms regulate human renin gene expression in Calu-6 cells
  228. NO DIFFERENCE IN THE PROPORTION OF INSULIN RECEPTOR EXON 11 +/‐ ISOFORM mRNA IN THE LIVER OF RATS AFTER DEVELOPMENT OF HYPERTENSION
  229. EXAMINATION OF THE ROLE OF NITRIC OXIDE SYNTHASE AND RENAL KALLIKREIN AS CANDIDATE GENES FOR ESSENTIAL HYPERTENSION
  230. Association analyses of NsiI RFLP of human insulin receptor gene in hypertensives
  231. Glucagon receptor gene mutation in essential hypertension
  232. SOME PHYSIOLOGICAL OUTCOMES OF RENIN GENE STUDIES
  233. Renin mRNA, Quantified by Polymerase Chain Reaction, in Renal Hypertensive Rat Tissues
  234. CROSS‐SECTIONAL STUDY OF A MICROSATELLITE MARKER IN THE LOW DENSITY LIPOPROTEIN RECEPTOR GENE IN OBESE NORMOTENSIVES
  235. RENIN mRNA CONCENTRATION IN RAT HYPOTHALAMUS IS DECREASED BY ENALAPRIL
  236. Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives
  237. Fourier Transform Infrared Spectroscopy of Dysplastic, Papillomavirus-Positive Cervicovaginal Lavage Specimens
  238. Human renin 5′-flanking DMA to nucleotide -2750
  239. Function of human renin proximal promoter DNA
  240. FREQUENCIES OF VARIANTS OF CANDIDATE GENES IN DIFFERENT AGE GROUPS OF HYPERTENSIVES
  241. SIMILARITY OF BLOOD PRESSURE FOR EACH GENOTYPE OF THE INSERTION/DELETION POLYMORPHISM OF THE DIPEPTIDYL CARBOXYPEPTIDASE‐1 GENE IN DIFFERENT AGE GROUPS OF PATIENTS WITH SEVERE, FAMILIAL ESSENTIAL HYPERTENSION
  242. Proximal 2.6 kb of 5′-flanking DNA is insufficient for human renin promoter activity in renin-synthesizing chorio-decidual cells
  243. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals.
  244. NO EFFECT OF KININS ON DNA SYNTHESIS IN LNCaP PROSTATE CANCER CELLS
  245. No difference in substrate affinity of plasma dipeptidyl carboxypeptidase-1 encoded by the I and D allelic forms of its gene
  246. Isolation and Structure of Cat Superfast Myosin Light Chain-2 cDNA and Evidence for the Identity of Its Human Homologue
  247. Significant Relationships of Plasma Lipids and Body Mass Index with Polymorphisms at the Linked Low-Density-Lipoprotein Receptor Gene and Insulin Receptor Gene Loci (19P13.2) in Essential Hypertensive Patients
  248. Identification of Cyclic AMP Response Element in the Human Renin Gene
  249. GENOTYPIC INFLUENCE ON PLASMA DIPEPTIDYL CARBOXYPEPTIDASE‐1 ACTIVITY IN HYPERTENSIVES
  250. Cross-Sectional Analysis of Met235→Thr Variant of Angiotensinogen Gene in Severe, Familial Hypertension
  251. Neuropeptide-Y Y1 Receptor Gene Polymorphism: Cross-Sectional Analyses in Essential Hypertension and Obesity
  252. Simple microwave and thermal cycler boiling methods for preparation of cervicovaginal lavage cell samples prior to PCR for human papillomavirus detection
  253. Independent, Marked Associations of Alleles of the Insulin Receptor and Dipeptidyl Carboxypeptidase-1 Genes with Essential Hypertension
  254. CHROMOSOME 17q23: A LOCUS FOR CARDIOVASCULAR DISEASE
  255. SPECIES DIFFERENCES IN BINDING OF SUBMANDIBULAR NUCLEAR PROTEINS TO RENIN PROMOTER DNA
  256. Renin messenger RNA, detected by polymerase chain reaction, can be switched on in rat atrium
  257. Identification of essential hypertension genes
  258. Reassignment of Human Renin Gene to Chromosome 1q32 in Studies of a (1;4)(q42;p16) Translocation
  259. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives
  260. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension
  261. Molecular biology of renin II: Gene control by messenger RNA, transfection and transgenic studies
  262. Molecular biology of renin I: Gene and protein structure, synthesis and processing
  263. Papillomavirus DNA and colposcopy instruments
  264. Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension
  265. Transient expression analyses of DNA extending 2.4 kb upstream of the human renin gene
  266. Prorenin and gene activation
  267. Association and linkage analyses of restriction fragment length polymorphisms for the human renin and antithrombin III genes in essential hypertension
  268. RENIN GENE EXPRESSION IN VARIOUS TISSUES DETERMINED BY SINGLE‐STEP POLYMERASE CHAIN REACTION
  269. A LOCUS ON THE LONG ARM OF CHROMOSOME 1 AS A POSSIBLE CAUSE OF ESSENTIAL HYPERTENSION
  270. Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men.
  271. Molecular genetics links renin to hypertension
  272. Localization of Human Glandular Kallikrein-1 Gene to Chromosome 19ql3.3–13.4 by in situ Hybridization
  273. Automated polymerase chain reaction for papillomavirus screening of cervicovaginal lavages: Comparison with dot‐blot hybridization in a sexually transmitted diseases clinic population
  274. Localization of human cardiac β-myosin heavy chain gene (MYH7) to chromosome 14q12 by in situ hybridization
  275. Human renin protein and gene structures: present and future targets for renin blockade in treatment of hypertension
  276. hGK‐1: A KALLIKREIN GENE EXPRESSED IN HUMAN PROSTATE
  277. Polymerase chain reaction for fast, nonradioactive detection of high‐ and low‐risk papillomavirus types in routine cervical specimens and in biopsies
  278. The B Subunit of Coagulation Factor XIII Is Linked to Renin and the Duffy Blood Group to α-Spectrin on Human Chromosome 1
  279. PAPILLOMAVIRUS SCREENING OF CERVICAL LAVAGES BY POLYMERASE CHAIN REACTION
  280. Triton WR-1339 injected into rats enters renal renin granules
  281. Human Papillomavirus: The Untreated Male Reservoir
  282. THREE Alu REPEATED SEQUENCES ASSOCIATED WITH A HUMAN GLANDULAR KALLIKREIN GENE
  283. Frequency in hypertensives of alleles for a RFLP associated with the renin gene
  284. Human Renin Gene: Extended Sequence of 5'-Flanking DNA and its Linkage to CAT Gene for Studies of Regulation
  285. Molecular Weights of Renin and Inactive Renin in Mouse Plasma
  286. Primary Structure of a Human Glandular Kallikrein Gene
  287. Detection of specific types of human papillomavirus in cervical scrapes, anal scrapes, and anogenital biopsies by DNA hybridization
  288. RENIN SECRETION FROM MALIGNANT PULMONARY METASTATIC TUMOUR CELLS OF VASCULAR ORIGIN
  289. Cell biology of cultured anogenital warts
  290. Regional chromosomal assignment of human renin gene to 1q12→qter and use in linkage studies in Charcot-Marie-Tooth disease
  291. ACTIVATION BY PUFF ADDER VENOM OF INACTIVE RENIN IN NORMAL AND HYPERTENSIVE RAT PLASMA
  292. Human cardiac myosin heavy chain genes. Isolation of a genomic DNA clone and its characterization and of a second unique clone also present in the human genome.
  293. New possibilities for intracellular renin and inactive renin now that the structure of the human renin gene has been elucidated
  294. Stimulation by thyroid hormone of renin mRNA in mouse submandibular gland
  295. EVOLUTION OF RENIN
  296. Antihypertensive Effect of Sialoadenectomy in One-Kidney, One Clip Hypertension in the Rat
  297. Studies of the Regulation of Mouse Renin Genes by Measurement of Renin Messenger Ribonucleic Acid*
  298. A STRUCTURAL ANALYSIS OF HUMAN RENIN
  299. ISOLATION OF GENOMIC CLONES CODING FOR THE HEAVY CHAINS OF TWO HUMAN CARDIAC MYOSINS
  300. Primary Structure of the Human Renin Gene
  301. STRUCTURE OF HUMAN RENIN AND EXPRESSION OF THE RENIN GENE
  302. DETECTION OF RENIN mRNA IN MOUSE KIDNEY AND SUBMANDIBULAR GLAND BY HYBRIDIZATION WITH RENIN cDNA*
  303. Immunohistochemistry of tonin in rat submandibular gland during development, lactation and secretion
  304. SYNTHESIS OF MOUSE RENIN AS A 2‐5‐33‐5 KILODALTON PRE‐PRO‐ TWO‐CHAIN MOLECULE AND USE OF ITS cDNA TO IDENTIFY THE HUMAN GENE
  305. PLASMA VASOPRESSIN IN HYPERCALCAEMIC STATES
  306. Clearance and Metabolism of125I-Labeled Tonin in the Rat*
  307. A simple method of isolating tonin using chromatofocusing
  308. The Effect of Bromocriptine on Circulating Vasopressin
  309. Investigation of the presence of "renopressin" in kidney extracts from rabbits and rats.
  310. Biosynthesis of Preprorenin. Studies Using Whole Tissue, A Cell-Free System, andE. ColiContaining cDna Inserted at thePstI Site of Plasmid pBR322
  311. Kallikrein and Renin: Molecular Biology and Biosynthesis
  312. BIOSYNTHESIS OF PREPRORENIN AND INTRACELLULAR CONVERSION OF PRORENIN TO RENIN
  313. Evidence that the arginine esteropeptidase (gamma) subunit of nerve growth factor can activate inactive renin
  314. Mechanism of activation of inactive renin in human plasma by puff adder venom
  315. Renin in mouse but not in rat submandibular glands
  316. ACTIVATION OF PLASMA PREKALLIKREIN AND INACTIVE RENIN BY PUFF ADDER VENOM
  317. Activation of inactive renin during the selective destruction of proteinase inhibitors in human plasma by a metalloproteinase in Bitis arietans venom
  318. Effect of angiotensin II and sodium depletion on angiotensinogen production
  319. Properties of inactive renin in human plasma
  320. Inhibitory by α-adrenoceptor agonists of renin release in vitro
  321. Localization of Angiotensinogen in Rat Liver by Immunocytochemistry*
  322. Partial purification of dog angiotensinogen.
  323. Properties of the activation by pepsin of inactive renin in human amniotic fluid
  324. A “Renin-Like” Enzymatic Action of Cathepsin D and the Similarity in Subcellular Distributions of “Renin-Like” Activity and Cathepsin D in the Midbrain of Dogs*
  325. The Distribution of Angiotensinogen in Dog Brain Studied by Cell Fractionation*
  326. The Renin-Angiotensin System
  327. Activation of Human Inactive (“Pro-”) Renin by Cathepsin D and Pepsin*
  328. Identification of “Angiotensin Immunoreactive Material” in Rat Kidney1
  329. Mechanism of interference by chelating agents and sucrose in radioimmunoassay of angiotensin I
  330. The renin-angiotensin-aldosterone system in rabbits with congestive heart failure produced by aortic constriction.
  331. Specific radioactivity of radioimmunoassay tracer determined by self-displacement: A re-evaluation
  332. Isolation of Renin Granules from Rat Kidney Cortex and Evidence for an Inactive Form of Renin (Prorenin) in Granules and Plasma
  333. Renin substrate in granules from rat kidney cortex
  334. RELEASE OF RENIN FROM GLOMERULI ISOLATED FROM RAT KIDNEY
  335. Renin Release from Isolated Rat Glomeruli
  336. Clearance from the circulation of the rat and whole‐body autoradiography in the mouse of 125I‐labelled neurophysins
  337. RELEASE AND CLEARANCE OF NEUROPHYSINS AND POSTERIOR PITUITARY HORMONES*
  338. CLEARANCE AND METABOLISM OF NEUROPHYSINS BY RAT KIDNEY
  339. The activation of renin in human amniotic fluid by proteolytic enzymes